Platelet Aggregation Devices Market
Number of pages: 100 | Report Format: PDF | Published date: May 01, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023 to 2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 419.7 million |
|
Revenue Forecast in 2031 |
US$ 1,847.41 million |
|
CAGR |
17.9% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Product, Application, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global platelet aggregation devices market was valued at US$ 419.7 million in 2022 and is expected to register a revenue CAGR of 17.9% to reach US$ 1,847.41 million by 2031.
Platelet Aggregation Devices Market Fundamentals
Platelet aggregation devices are used to assess platelet function in vitro (outside the body) by measuring the degree to which platelets in a blood sample clump together, or aggregate, in response to a particular stimulus. There are several different types of platelet aggregation devices. Still, they generally work by adding a stimulus, such as a chemical or physical agent, to a sample of blood collected from a patient and then measuring the degree of aggregation using optical or electrical methods. Platelet aggregation devices are commonly used to diagnose and manage bleeding disorders, such as von Willebrand disease and platelet function disorders. They may also be used to monitor patients undergoing antiplatelet therapy, such as those taking aspirin or clopidogrel, to ensure their medication effectively prevents blood clots. Some examples of platelet aggregation devices include the Platelet works system, the Verify Now system, and the multiplate analyzer. These devices vary in their methods and technology, but all simultaneously measure platelet function in vitro.
[12]
Platelet Aggregation Devices Market Dynamics
Cardiovascular illnesses such as heart attacks and stroke are the major drivers of the increasing need for platelet aggregation devices. Cardiovascular illnesses are the biggest cause of mortality globally, killing an estimated 17.9 million people yearly, according to the World Health Organization. As a result, demand for platelet aggregation devices is expected to rise over the next several years. Additionally, platelet aggregation devices are becoming more common in point-of-care diagnostic environments. These devices give real-time information on platelet function, enabling the early detection and treatment of problems such as bleeding disorders and thrombotic events. The increased need for point-of-care diagnostics will likely propel the platelet aggregation devices market forward. Moreover, these devices have become more precise and efficient because of technological improvements. Light transmission aggregometry (LTA) and impedance aggregometry (IA), for instance, have considerably increased the accuracy of platelet function tests. Introducing new technologies is expected to propel the platelet aggregation devices market forward. The use of platelet-rich plasma in PRP treatment promotes healing and tissue regeneration. Platelet aggregation devices isolate and concentrate platelets for PRP treatment. The increased need for PRP therapy is projected to propel the platelet aggregation devices market forward. The aging population is more prone to cardiovascular diseases, and as the population ages, the demand for platelet aggregation devices will likely increase.
However, these platelet aggregation devices are expensive, which makes them unaffordable for many patients and healthcare facilities. This limits their adoption and use, particularly in low-income countries and regions. Many healthcare professionals and patients are not aware of the benefits and applications of platelet aggregation devices. This limits their adoption and use, particularly in emerging markets and low-income countries. Platelet aggregation devices are classified as medical devices and are subject to stringent regulatory requirements in most countries. This can delay their approval and commercialization, limiting their adoption and use. Platelet aggregation devices require skilled healthcare professionals to operate and interpret the results. The limited availability of such professionals can limit the adoption and use of platelet aggregation devices, particularly in low-income countries and regions. The reimbursement policies for platelet aggregation devices vary widely across different countries and regions. The limited coverage and reimbursement policies can limit their adoption and use, particularly in low-income countries and regions where patients may not be able to afford the cost of these devices.
Platelet Aggregation Devices Market Ecosystem
The global platelet aggregation devices market has been analyzed from the following perspectives: product, application, end user, and region.
Platelet Aggregation Devices Market by Product
[21]
Based on the products, the global platelet aggregation devices market is segmented into systems, reagents, and consumables & accessories.
The system segment registered the largest revenue share in the global market in 2022. Platelet aggregation systems have undergone significant technological advancements in recent years, which have improved their accuracy and efficiency. For instance, new systems can measure platelet function more precisely and quickly, allowing for more accurate diagnoses and treatment plans. Platelet aggregation systems have a wide range of applications, including diagnosing and treating bleeding disorders, thrombotic events, and cardiovascular diseases. This makes them an essential tool for healthcare professionals, driving their adoption and use. Point-of-care testing is becoming increasingly popular in healthcare settings, allowing for faster and more accurate diagnosis and treatment. Platelet aggregation systems are an important part of point-of-care testing, making them an essential tool in healthcare settings. The platelet aggregation devices market has seen increased funding for research and development, which has led to the development of new and improved platelet aggregation systems. This has driven the growth of the system segment of the market. Cardiovascular diseases are a major contributor to cardiovascular diseases and mortality, driving the demand for platelet aggregation systems. As the prevalence of cardiovascular diseases continues to rise, the demand for platelet aggregation systems is expected to grow, further driving the market's growth of the system segment.
Platelet Aggregation Devices Market by Application
Based on the applications, the global platelet aggregation devices are segmented into research and clinical.
The clinical segment dominates the global platelet aggregation devices market for several reasons. Cardiovascular diseases, such as heart attacks and strokes, are major contributors to the global burden of disease and mortality. Platelet aggregation devices are used to diagnose and treat these conditions, making them an essential tool in clinical settings. Point-of-care testing is becoming increasingly popular in clinical settings, allowing for faster and more accurate diagnosis and treatment. Platelet aggregation devices are an important part of point-of-care testing, making them an essential tool in clinical settings. Technological advancements in platelet aggregation devices have led to the development of more accurate and efficient devices, making them an important tool in clinical settings. Personalized medicine involves tailoring treatment to individual patients based on their specific genetic, environmental, and lifestyle factors. Platelet aggregation devices are used in personalized medicine to determine the most effective treatment for individual patients, making them an essential tool in clinical settings. Governments and private organizations are investing heavily in healthcare infrastructure, which is driving the growth of the clinical segment of the platelet aggregation devices market. This investment is increasing the availability and accessibility of platelet aggregation devices in clinical settings, driving their adoption and use.
Platelet Aggregation Devices Market by End User
Based on the end users, the global platelet aggregation devices market is segmented into hospitals, diagnostic centers, and others.
The hospital segment accounts for the largest revenue share in the global market. Hospitals tend to have high patient volumes, which increases the demand for platelet aggregation devices. The high patient volumes also make it more cost-effective for hospitals to invest in these devices, further driving their adoption and use. Platelet aggregation devices require skilled healthcare professionals to operate and interpret the results. Hospitals tend to have a higher concentration of such professionals, making them an ideal setting for platelet aggregation devices. Platelet aggregation devices have a wide range of applications, including diagnosing and treating bleeding disorders, thrombotic events, and cardiovascular diseases. Hospitals tend to have a wide range of patients with these conditions, making them an ideal setting for platelet aggregation devices. Hospitals tend to have greater access to funding and resources than other healthcare settings, allowing them to invest in the latest platelet aggregation devices and technology. Hospitals strongly emphasize quality of care, including the use of the latest and most advanced medical devices. Platelet aggregation devices are an important tool for improving the quality of care for patients with bleeding disorders, thrombotic events, and cardiovascular diseases, driving their adoption and use in hospitals.
Platelet Aggregation Devices Market by Region
Based on the region, the global platelet aggregation devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America dominates the global market with the largest revenue share. North America has a high prevalence of cardiovascular diseases, such as heart attacks and strokes, which drives the demand for platelet aggregation devices. These devices are used to diagnose and treat these conditions, making them an essential tool in healthcare settings. North America has advanced healthcare infrastructure, which includes a high concentration of hospitals and healthcare facilities. This infrastructure facilitates the adoption and use of platelet aggregation devices. North American healthcare systems strongly emphasize quality of care, including the use of the latest and most advanced medical devices. Platelet aggregation devices are an important tool for improving the quality of care for patients with bleeding disorders, thrombotic events, and cardiovascular diseases, driving their adoption and use in the region. North America is home to many leading medical device companies, which drive technological advancements in the platelet aggregation devices market. These advancements improve the accuracy and efficiency of platelet aggregation devices, making them an essential tool in healthcare settings. North American governments provide funding and support for medical research and development, which drives the innovation and development of new platelet aggregation devices. This supports the growth of the market in the region.
Asia Pacific is the fastest-growing region in the global market. There has been a rise in the number of patients with platelet-related disorders in the Asia Pacific region, leading to an increased demand for platelet aggregation devices. This could be due to changing lifestyles, increasing prevalence of chronic diseases, and rising healthcare spending. The Asia Pacific region has witnessed significant growth in healthcare infrastructure, including hospitals, clinics, and diagnostic centers. This has led to an increased availability of platelet aggregation devices in the region. Significant technological advancements have been made in the development of platelet aggregation devices, leading to better diagnostic accuracy, increased efficiency, and enhanced patient outcomes. The Asia Pacific region has quickly adopted these advancements, increasing demand for these devices. Many governments in the Asia Pacific region have implemented initiatives to improve healthcare access and outcomes. This has increased awareness about platelet-related disorders and a greater emphasis on early diagnosis and treatment, leading to a rise in demand for platelet aggregation devices.
Competitive Landscape
The prominent players operating in the global platelet aggregation devices market are:
Strategic Development
Platelet aggregation devices are medical devices used to assess platelet function in vitro by measuring the degree to which platelets in a blood sample clump together, or aggregate, in response to a particular stimulus.
The global platelet aggregation devices market is expected to be US$ 419.41 million in 2031.
The high cost of the devices and strict regulatory policies can prove to be major hurdles in the optimal growth of this market.
The rise in the prevalence of cardiovascular diseases, technological advancement, and rapid growth in R&D activities are some factors driving the market growth.
North America dominates the global platelet aggregation devices market.
*Insights on financial performance are subject to the availability of information in the public domain